Borealis Biosciences, Inc.

Borealis Biosciences, Inc. is at the forefront of biotechnology research, dedicated to pioneering RNA medicines for kidney disease and expanding the horizon of therapeutic possibilities. With a foundation built on the convergence of scientific and translational breakthroughs, Borealis Biosciences is committed to advancing innovative treatments and improving patient outcomes.

Borealis Biosciences benefits from the backing of founding investor Versant Ventures and Novartis AG, complemented by a strategic collaboration with a leading pharmaceutical company. This collaborative approach ensures that Borealis Biosciences remains agile and responsive to the evolving needs of the healthcare landscape, driving progress in RNA medicine and beyond. The company is poised to make significant contributions to the field, enhancing the quality of life for individuals affected by kidney diseases.

Borealis Biosciences, Inc. is dedicated to pushing the boundaries of biotechnology and transforming scientific discoveries into tangible healthcare solutions. We invite the manager of Borealis Biosciences to create a customized and exclusive company showcase and product listing on our platform, to further highlight their groundbreaking work and connect with a broader audience.